Study of Duodenal Mucosal RF Vapor Ablation in Subjects With Type-2 Diabetes Mellitus

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 2, 2023

Primary Completion Date

January 31, 2026

Study Completion Date

June 30, 2026

Conditions
Diabetes Mellitus Type 2
Interventions
DEVICE

RF Vapor Ablation

RF Vapor ablation of the duodenum

Trial Locations (1)

Unknown

RECRUITING

Clinica Colonial, Santiago

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Aqua Medical, Inc.

INDUSTRY

NCT05887635 - Study of Duodenal Mucosal RF Vapor Ablation in Subjects With Type-2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter